TENSILON PRESERVATIVE FREE (edrophonium chloride) by R-Pharm US. Approved for depression. First approved in 1951.
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
Tensilon Preservative Free is an injectable formulation of edrophonium chloride, a cholinesterase inhibitor approved in 1951. It is indicated for depression and works by inhibiting acetylcholinesterase, thereby increasing acetylcholine levels in the central nervous system. The preservative-free formulation addresses manufacturing and safety requirements for injectable administration.
As an aging injectable with LOE approaching, this product likely operates with a small specialized team focused on market defense and existing customer retention rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Working on Tensilon Preservative Free offers limited career growth potential given its LOE-approaching status and zero linked job openings. This role suits professionals seeking expertise in legacy product management, market defense, or specialty injectable administration rather than growth-driven commercial careers.
Worked on TENSILON PRESERVATIVE FREE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.